COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 2831: Articles 28301-28310  | Next

Mutational spectra of SARS-CoV-2 orf1ab polyprotein and Signature mutations in the United States of America
Banerjee, S., Seal, S., Dey, R., Mondal, K. k., Bhattacharjee, P.
10.1101/2020.05.01.071654 — Posted: 2020-05-01
Heat inactivation of the Severe Acute Respiratory Syndrome Coronavirus 2
Batejat, C., Grassin, Q., Manuguerra, J.-C., Leclercq, I.
10.1101/2020.05.01.067769 — Posted: 2020-05-01 Discussion: Onsite
SARS-CoV-2 spike protein predicted to form stable complexes with host receptor protein orthologues from mammals, but not fish, birds or reptiles
Lam, S. D., Bordin, N., Waman, V. P., Scholes, H. M., Ashford, P., Sen, N., van Dorp, L., Rauer, C., Dawson, N. L., Pang, C. S., Abbasian, M., Sillitoe, I., Edwards, S. J., Fraternali, F., Lees, J. G., Santini, J. M., Orengo, C. A.
10.1101/2020.05.01.072371 — Posted: 2020-05-01
SARS-CoV2 quantification using RT-dPCR: a faster and safer alternative to assist viral genomic copies assessment using RT-qPCR
Almeida, P. R., Demoliner, M., Antunes Eisen, A. K., Heldt, F. H., Hansen, A. W., Schallenberger, K., Fleck, J. D., Spilki, F. R.
10.1101/2020.05.01.072728 — Posted: 2020-05-01
Distinct Inductions of and Responses to Type I and Type III Interferons PromoteInfections in Two SARS-CoV-2 Isolates
Hsin, F., Chao, T.-L., Chan, Y.-R., Kao, H.-C., Liu, W.-D., Wang, J.-T., Pang, Y.-H., Lin, C.-H., Tsai, Y.-M., Lin, J.-Y., Chang, S.-Y., Liu, H. M.
10.1101/2020.04.30.071357 — Posted: 2020-05-01 Discussion: Onsite
SARS-CoV-2 genomes recovered by long amplicon tiling multiplex approach using nanopore sequencing and applicable to other sequencing platforms
Resende, P. C., Motta, F. C., Roy, S., Appolinario, L., Fabri, A., Xavier, J., Harris, K., Matos, A. R., Caetano, B. C., Garcia, C. C., Miranda, M. D., Ogrzewalska, M., Abreu, A., Williams, R., Breuer, J., Siqueira, M. M.
10.1101/2020.04.30.069039 — Posted: 2020-05-01
Potent antiviral effect of protoporphyrin IX and verteporfin on SARS-CoV-2 infection
Gu, C., Wu, Y., Guo, H., Zhu, Y., Xu, W., Wang, Y., Sun, Z., Cai, X., Li, Y., Liu, J., Yuan, Z., Zhang, R., Deng, Q., Qu, D., Xie, Y.
10.1101/2020.04.30.071290 — Posted: 2020-05-01
Comparative transcriptome analysis reveals the intensive early-stage responses of host cells to SARS-CoV-2 infection
Sun, J., Ye, F., Wu, A., Yang, R., Pan, M., Sheng, J., Zhu, W., Mao, L., Wang, M., Huang, B., Tan, W., Jiang, T.
10.1101/2020.04.30.071274 — Posted: 2020-05-01
Dysregulation in mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
Appelberg, S., Gupta, S., Ambikan, A. T., Mikaeloff, F., Vegvari, A., Svensson Akusjarvi, S., Benfeitas, R., Sperk, M., Stahlberg, M., Krishnan, S., Singh, K., Penninger, J. M., Mirazimi, A., Neogi, U.
10.1101/2020.04.30.070383 — Posted: 2020-05-01 Discussion: Offsite
Electrostatic Characteristics of SARS-CoV-2 Spike and Human ACE2 Protein Variations Predict Mutable Binding Efficacy
Morton, S. P., Phillips, J. L.
10.1101/2020.04.30.071175 — Posted: 2020-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).